The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?-Reference-Cited by-同舟云学术

The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?

Published:2016-10-17 Issue:1 Volume:176 Page:124-130
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Vitrano Angela¹,Calvaruso Giuseppina¹,Lai Eliana²,Colletta Grazia³,Quota Alessandra⁴,Gerardi Calogera⁵,Concetta Rigoli Luciana⁶,Pitrolo Lorella¹,Cuccia Liana⁷,Gagliardotto Francesco⁷,Filosa Aldo⁸,Caruso Vincenzo⁹,Argento Crocetta¹⁰,Campisi Saveria¹¹,Rizzo Michele¹²,Prossomariti Luciano¹³,Fidone Carmelo¹⁴,Fustaneo Maria¹,Di Maggio Rosario¹,Maggio Aurelio¹

Affiliation:

1. Campus of Haematology Franco e Piera Cutino - A.O.O.R. “Villa Sofia-Cervello”; Palermo Italy

2. Ospedale microcitemico; Centro Talassemici Adulti; University of Cagliari; Cagliari Italy

3. Azienda Ospedaliera Università Policlinico “Vittorio Emanuele - P.O. Ferrarotto”; Catania Italy

4. U.O.S Talassemia P.O. Vittorio Emanuele; Gela (CL) Italy

5. U.O.S. di Talassemia P.O. “Giovanni Paolo II” Sciacca; Sciacca Italy

6. U.O. Genetica ed Immunologia Pediatrica; Policlinico “G. Martino”; Messina Italy

7. U.O.C. 7 Pediatria per le Emopatie Ereditarie; Centro di Prevenzione Diagnosi e Cura della Talassemia; A.O. “G. Di Cristina”; Palermo Italy

8. U.O.D. Malattie Rare del Globulo Rosso; A.O.R.N. “A. Cardarelli”; Napoli Italy

9. U.O. Talassemia Ospedale Garibaldi; Catania Italy

10. U.O.C. Medicina Trasfusionale; A.O. “S. Giovanni di Dio”; Agrigento Italy

11. U.O.S. Talassemia; A.O. Umberto I; Siracusa Italy

12. U.O.C. Ematologia; A.O. “S. ELIA”; Caltanissetta Italy

13. Centro Microcitemia; A.O. B.M.M.; Reggio Calabria Italy

14. U.O.C. Centro Trasfusionale; A.O. “M. Paternò Arezzo”; Ragusa Italy

Funder

Foundation Franco

Piera Cutino

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14381/fullpdf

Reference41 articles.

1. Thalassemia intermedia today: should patients regularly receive transfusions?;Aessopos;Transfusion,2007

2. Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2* in patients with thalassemia major on various chelation regimens: a 6-year study;Ambati;American Journal of Hematology,2013

3. Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload;Aydinok;Blood,2015

4. Survival and complications in thalassemia;Borgna-Pignatti;Haematologica,2004a

5. Hepatocellular carcinoma in the thalassaemia syndromes;Borgna-Pignatti;British Journal of Haematology,2004b

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transfusion in hemoglobinopathies and red blood cell alloimmunization: data from Sicily, Sardinia and Malta;BLOOD TRANSFUS-ITALY;2024

2. Hemoglobinopathies (Sickle Cell Disease and Thalassemia);The EBMT Handbook;2024

3. Pregnancy and assisted reproductive technology use in Australian female transfusion‐dependent haemoglobinopathy patients: a 20‐year retrospective analysis;Internal Medicine Journal;2023-07-14

4. An Epidemiological Study of the Quality of Life of Children With Beta-Thalassemia Major (β-TM) and Its Correlates in Kolkata, West Bengal, India;Cureus;2023-03-29

5. Effects of Ramadan Intermittent Fasting on the Severity of β-Thalassemia Major Patients;Cureus;2023-03-27